High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.1M
$5,134,722
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$940,528x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $940,528x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-02-02
$505,710
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $505,710 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-11-24
$1,485,755Large
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-24 | $1,485,755Large | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-11-21
$31,650
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-21 | $31,650 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2025-11-03
$285,399x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $285,399x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-28
$1,001,032Large
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-28 | $1,001,032Large | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-02
$415,574
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-02 | $415,574 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-01
$469,074x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-01 | $469,074x2 | S | Form 4 |